Ressources numériques en sciences humaines et sociales OpenEdition Nos plateformes OpenEdition Books OpenEdition Journals Hypothèses Calenda Bibliothèques OpenEdition Freemium Suivez-nous

Market Access in Canada and Challenges for Orphan and Ultra-Orphan Diseases

Healthcare in Canada has been identified as being fragmented, and obtaining Market Access is cumbersome and lengthy. Rare diseases are a complex issue but account for a large amount of healthcare spending. Currently there is no orphan medicine framework in Canada. Planned changes announced by the Patented Medicines Pricing and Review Board (PMPRB) to promote fair and equal pricing to medicines, may see the prices of drugs for rare diseases being reduced significantly, making Canada a less attractive market for pharma in the future.

Read more on the MAP market access blog: https://www.mappatientaccess.com/blog/?post=market-access-in-canada


OpenEdition vous propose de citer ce billet de la manière suivante :
egennet (17 mai 2022). Market Access in Canada and Challenges for Orphan and Ultra-Orphan Diseases. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/o5zc


Vous aimerez aussi...

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

This site uses Akismet to reduce spam. Learn how your comment data is processed.